Yubo International Biotech Ltd
OTC:YBGJ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Y
|
Yubo International Biotech Ltd
OTC:YBGJ
|
CN |
Income Statement
Earnings Waterfall
Yubo International Biotech Ltd
Income Statement
Yubo International Biotech Ltd
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
1
N/A
|
0
-43%
|
0
-18%
|
0
-72%
|
0
+136%
|
1
+165%
|
1
-7%
|
0
-25%
|
|
| Gross Profit | |||||||||
| Cost of Revenue |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Gross Profit |
1
N/A
|
0
-40%
|
0
-21%
|
0
-78%
|
0
+94%
|
0
+322%
|
0
-3%
|
0
-13%
|
|
| Operating Income | |||||||||
| Operating Expenses |
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
|
| Selling, General & Administrative |
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
(1)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
|
| Operating Income |
(2)
N/A
|
(2)
-7%
|
(2)
+6%
|
(1)
+29%
|
(1)
+22%
|
(0)
+78%
|
(1)
-478%
|
(1)
+23%
|
|
| Pre-Tax Income | |||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
(2)
N/A
|
(2)
-7%
|
(2)
+5%
|
(1)
+29%
|
(1)
+22%
|
(0)
+78%
|
(1)
-478%
|
(1)
+23%
|
|
| Net Income | |||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(2)
N/A
|
(2)
-7%
|
(2)
+5%
|
(1)
+29%
|
(1)
+22%
|
(0)
+78%
|
(1)
-478%
|
(1)
+26%
|
|
| EPS (Diluted) |
-0.01
N/A
|
-0.02
-100%
|
-0.01
+50%
|
-0.01
N/A
|
-0.01
N/A
|
0
N/A
|
-0.01
N/A
|
-0.01
N/A
|
|